Literature DB >> 22430631

Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.

B H Yip, A Pellagatti, C Vuppusetty, A Giagounidis, U Germing, A A Lamikanra, D J Roberts, M Fernandez-Mercado, E-J McDonald, S Killick, J S Wainscoat, J Boultwood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22430631     DOI： 10.1038/leu.2012.82

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  Bone Marrow Failure Syndromes: The Ribosomopathies.

Authors:  Arati Khanna-Gupta
Journal:  J Bone Marrow Res       Date:  2013-01-10

2.  L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients.

Authors:  Erica Bello; Jonathan Kerry; Shalini Singh; Bon Ham Yip; Rajko Kušec; Sally Killick; Sophie Raynaud; Jacqueline Boultwood; Andrea Pellagatti
Journal:  Haematologica       Date:  2018-06-14       Impact factor: 9.941

3.  Reduced translation of GATA1 in Diamond-Blackfan anemia.

Authors:  Jacqueline Boultwood; Andrea Pellagatti
Journal:  Nat Med       Date:  2014-07       Impact factor: 53.440

4.  L-Leucine improves the anaemia in models of Diamond Blackfan anaemia and the 5q- syndrome in a TP53-independent way.

Authors:  Anupama Narla; Elspeth M Payne; Nirmalee Abayasekara; Slater N Hurst; David M Raiser; A Thomas Look; Nancy Berliner; Benjamin L Ebert; Arati Khanna-Gupta
Journal:  Br J Haematol       Date:  2014-08-07       Impact factor: 6.998

5.  Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations.

Authors:  Andrea Pellagatti; Richard N Armstrong; Violetta Steeples; Eshita Sharma; Emmanouela Repapi; Shalini Singh; Andrea Sanchi; Aleksandar Radujkovic; Patrick Horn; Hamid Dolatshad; Swagata Roy; John Broxholme; Helen Lockstone; Stephen Taylor; Aristoteles Giagounidis; Paresh Vyas; Anna Schuh; Angela Hamblin; Elli Papaemmanuil; Sally Killick; Luca Malcovati; Marco L Hennrich; Anne-Claude Gavin; Anthony D Ho; Thomas Luft; Eva Hellström-Lindberg; Mario Cazzola; Christopher W J Smith; Stephen Smith; Jacqueline Boultwood
Journal:  Blood       Date:  2018-06-21       Impact factor: 22.113

Review 6.  Recent Advances in the 5q- Syndrome.

Authors:  Andrea Pellagatti; Jacqueline Boultwood
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-05-20       Impact factor: 2.576

7.  Branched-chain amino acids are linked with iron metabolism.

Authors:  Dietmar Enko; Thomas Moro; Sandra Holasek; Andreas Baranyi; Wolfgang J Schnedl; Sieglinde Zelzer; Harald Mangge; Markus Herrmann; Andreas Meinitzer
Journal:  Ann Transl Med       Date:  2020-12

8.  TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients.

Authors:  Gisela Caceres; Kathy McGraw; Bon Ham Yip; Andrea Pellagatti; Joseph Johnson; Ling Zhang; Kenian Liu; Lan Min Zhang; William J Fulp; Ji-Hyun Lee; Najla H Al Ali; Ashley Basiorka; Larry J Smith; F Joseph Daugherty; Neil Littleton; Richard A Wells; Lubomir Sokol; Sheng Wei; Rami S Komrokji; Jacqueline Boultwood; Alan F List
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

9.  Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.

Authors:  H Dolatshad; A Pellagatti; M Fernandez-Mercado; B H Yip; L Malcovati; M Attwood; B Przychodzen; N Sahgal; A A Kanapin; H Lockstone; L Scifo; P Vandenberghe; E Papaemmanuil; C W J Smith; P J Campbell; S Ogawa; J P Maciejewski; M Cazzola; K I Savage; J Boultwood
Journal:  Leukemia       Date:  2014-11-27       Impact factor: 11.528
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.